Profil
Harvey J.
Berger was the founder of ARIAD Pharmaceuticals, Inc., founded in 1991, where the titles held included Chairman, President & Chief Executive Officer from 2004 to 2015.
Current jobs include Director at Cameron Boyce Foundation; Trustee at Dana-Farber Cancer Institute, Inc. since 2018; Member-Deans Council at Yale University since 2013; and Member-Deans Council at Yale School of Medicine.
Former jobs include Chairman, President & Chief Executive Officer at Kojin Therapeutics, Inc.; Executive Chairman-USA Region at Medinol Ltd.; and EVP, President-Research & Development Division at Centocor, Inc. from 1986 to 1991.
Education history includes undergraduate degree from Colgate University and doctorate from Yale School of Medicine.
Postes actifs de Harvey Berger
| Sociétés | Poste | Début |
|---|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Directeur/Membre du Conseil | 21/02/2018 |
Cameron Boyce Foundation
Cameron Boyce Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a foundation for research, education and awareness campaigns | Directeur/Membre du Conseil | - |
Anciens postes connus de Harvey Berger
| Sociétés | Poste | Fin |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Directeur Général | 31/12/2015 |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Directeur Technique/Scientifique/R&D | 01/01/1991 |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | Directeur Général | - |
Medinol Ltd.
Medinol Ltd. Medical SpecialtiesHealth Technology Manufactures surgical devices for heart | Corporate Officer/Principal | - |
Formation de Harvey Berger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Colgate University
Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medinol Ltd.
Medinol Ltd. Medical SpecialtiesHealth Technology Manufactures surgical devices for heart | Health Technology |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | Health Technology |
Cameron Boyce Foundation
Cameron Boyce Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a foundation for research, education and awareness campaigns | Miscellaneous |
















